Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: Evaluation in vitro and in vivo

Bioconjugate Chemistry

Volumn 14, Issue 4, 2003, Pages 738-747

  Leamon, Christopher P ^a,b   Cooper, Scott R ^a   Hardee, Gregory E ^a  

^a ISIS PHARMACEUTICALS   (United States)

^b Endocyte Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ASSOCIATION REACTIONS; CELL CULTURE; CELLS; CHAINS; LIPOSOMES; TUMORS;

ANTISENSE OLIGODEOXYNUCLEOTIDES; CANCER CELLS; FOLATE RECEPTOR; FOLATES; IN-VITRO; IN-VIVO; SYNTHESIS EVALUATION; TUMOR UPTAKE; TUMOUR CELLS; VITRO AND IN VIVO;

OLIGONUCLEOTIDES;

4 AMINOBUTYRIC ACID; ANTISENSE OLIGODEOXYNUCLEOTIDE; CYSTEINE; FOLIC ACID; FOLIC ACID DERIVATIVE; GLYCINE; LIPOSOME; MACROGOL; PTEROIC ACID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL INTERACTION; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; HUMAN; HUMAN CELL; HYDROPHILICITY; MOLECULAR WEIGHT; MOUSE; NONHUMAN;

ANIMALIA; MUS MUSCULUS;

EID: 0038116522     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc020089t     Document Type: Article

References (67)

1. Toulme, J. J., and Helene, C. (1988) Antimessenger oligodeoxyribonucleotides: an alternative to antisense RNA for artificial regulation of gene expression - a review. Gene 72, 51-58.
2. Tonkinson, J. L., and Stein, C. A. (1996) Antisense oligodeoxynucleotides as clinical therapeutic agents. Cancer Invest. 14, 54-65.
3. Chiang, M. Y., Chan, H., Zounes, M. A., Freier, S. M., Lima, W. F., and Bennett, C. F. (1991) Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem. 266, 18162-18171.
4. Dean, N. M., McKay, R., Condon, T. P., and Bennett, C. F. (1994) Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J. Biol. Chem. 269, 16416-16424.
5. Skorski, T., Nieborowska-Skorska, M., Nicolaides, N. C., Szczylik, C., Iversen, P., Iozzo, R. V., Zon, G., and Calabretta, B. (1994) Suppression of Philadelphial leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide. Proc. Natl. Acad. Sci. U.S.A. 91, 4504-4508.
6. Cohen, J. S. (1991) Antisense oligodeoxynucleotides as antiviral agents. Antiviral Res. 16, 121-133.
7. Crooke, S. T. (1992) Therapeutic applications of oligonucleotides. Annu Rev. Pharmacol. Toxicol. 32, 329-376.
8. Stein, C. A., and Cheng, Y. C. (1993) Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 261, 1004-1012.
9. Cossum, P. A., Sasmor, H., Dellinger, D., Truong, L., Cummins, L., Owens, S. R., Markham, P. M., Shea, J. P., and Crooke, S. (1993) Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats. J. Pharmacol. Exp. Ther. 267, 1181-1190.
10. 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats. J. Pharmacol. Exp. Ther. 269, 89-94.
11. Dewanjee, M. K., Ghafouripour, A. K., Kapadvanjwala, M., Dewanjee, S., Serafini, A. N., Lopez, D. M., and Sfakianakis, G. N. (1994) Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model. J. Nucl. Med. 35, 1054-1063.
12. Yakubov, L. A., Deeva, E. A., Zarytova, V. F., Ivanova, E. M., Ryte, A. S., Yurchenko, L. V., and Vlassov, V. V. (1989) Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc. Natl. Acad. Sci. U.S.A. 86, 6454-6458.
13. Graham, M. J., Crooke, S. T., Monteith, D. K., Cooper, S. R., Lemonidis, K. M., Stecker, K. K., Martin, M. J., and Crooke, R. M. (1998) In vivo distribution and metabolism of a phosphorothioate oligonucleotide within rat liver after intravenous administration. J. Pharmacol. Exp. Ther. 286, 447-458.
14. Wang, H., Nan, L., Yu, D., Agrawal, S., and Zhang, R. (2001) Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms. Clin. Cancer Res. 7, 3613-3624.
15. Crooke, S. T. (2000) Potential roles of antisense technology in cancer chemotherapy. Oncogene 19, 6651-6659.
16. Stuart, D. D., and Allen, T. M. (2000) A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability. Biochim. Biophys. Acta 1463, 219-29.
17. Nakamura, N., Timmermann, S. A., Hart, D. A., Kaneda, Y., Shrive, N. G., Shino, K., Ochi, T., and Frank, C. B. (1998) A comparison of in vivo gene delivery methods for antisense therapy in ligament healing. Gene Ther 5, 1455-1461.
18. Zelphati, O., Zon, G., and Leserman, L. (1993) Inhibition of HIV-1 replication in cultured cells with antisense oligonucleotides encapsulated in immunoliposomes. Antisense Res. Dev. 3, 323-338.
19. Pastorino, F., Stuart, D., Ponzoni, M., and Allen, T. M. (2001) Targeted delivery of antisense oligonucleotides in cancer. J Controlled Release 74, 69-75.
20. Allen, T. M. (1994) The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv. Drug Deliv. Rev. 13, 285-309.
21. Stuart, D. D., Kao, G. Y., and Allen, T. M. (2000) A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1. Cancer Gene Ther. 7, 466-475.
22. Lopes de Menezes, D. E., Pilarski, L. M., and Allen, T. M. (1998) In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. Cancer Res. 58, 3320-3330.
23. Lee, R. J., and Low, P. S. (1994) Delivery of Liposomes into Cultured KB Cells via Folate Receptor-mediated Endocytosis. J. Biol. Chem. 269, 3198-3204.
24. Pagnan, G., Montaldo, P. G., Pastorino, F., Raffaghello, L., Kirchmeier, M., Allen, T. M., and Ponzoni, M. (1999) GD2-mediated melanoma cell targeting and cytotoxicity of liposome-entrapped fenretinide. Int. J. Cancer 81, 268-274.
25. Zalipsky, S., Mullah, N., Harding, J. A., Gittelman, J., Guo, L., and DeFrees, S. A. (1997) Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains. Bioconjugate Chem. 8, 111-118.
26. Leamon, C. P., and Low, P. S. (1991) Delivery of Macromolecules into Living Cells: A Method that Exploits Folate Receptor Endocytosis. Proc. Natl. Acad. Sci., U.S.A. 88, 5572-5576.
27. 67Ga-deferoxamine-folate, a potential radiopharmaceutical for tumor imaging. Bioconjugate Chem. 7, 56-62.
28. Mathias, C. J., Wang, S., Lee, R. J., Waters, D. J., Low, P. S., and Green, M. A. (1996) Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of Gallium-67-deferoxamine-folate. J. Nucl. Med. 37, 1003-1008.
29. Mathias, C. J., Wang, S., Waters, D. J., Turek, J. J., Low, P. S., and Green, M. A. (1998) Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical. J. Nucl. Med. 39, 1579-1585.
30. 99mTc-Ethylenedicysteine-folate: A new tumor imaging agent. Synthesis, labeling and evaluation in animals. Cancer Biother. Radiopharm. 13, 427-435.
31. 99mTc-HYNIC-folate: A novel receptor-based targeted radiopharmaceutical for tumor imaging. J. Nucl. Med. 40, 1563-1569.
32. 99mTc-OXA-Folate show uptake of both isomers in folate-receptor (+) KB cell lines. Soc. Nucl. Med.; Proc. 47th Annu. Meet. 41, 119P.
33. Konda, S. D., Aref, M., Brechbiel, M., and Wiener, E. C. (2000) Development of a tumor-targeting MR contrast agent using the high-affinity folate receptor. Investigative Radiology 35, 50-57.
34. Ladino, C. A., Chari, R. V. J., Bourret, L. A., Kedersha, N. L., and Goldmacher, V. S. (1997) Folate-maytansinoids: Target-selective drugs of low molecular weight. Int. J. Cancer 73, 859-864.
35. Citro, G., Szczylik, C., Ginobbi, P., Zupi, G., and Calabretta, B. (1994) Inhibition of leukaemia cell proliferation by folic acid - polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells. Br. J. Cancer 69, 463-467.
36. Wang, S., Lee, R. J., Cauchon, G., Gorenstein, D. G., and Low, P. S. (1995) Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via poly(ethylene glycol). Proc. Natl. Acad. Sci., U.S.A. 92, 3318-3322.
37. Li, S., and Huang, L. (1997) Targeted delivery of antisense oligodeoxynucleotides by LPDII. J. Liposome Res. 7, 63-75.
38. Li, S., and Huang, L. (1998) Targeted delivery of antisense oligodeoxynucleotides formulated in a novel lipidic vector. J. Liposome Res. 8, 239-250.
39. Li, S., Deshmukh, H. M., and Huang, L. (1998) Folate-mediated targeting of antisense oligonucleotides to ovarian cancer cells. Pharm. Res. 15, 1540-1545.
40. Leopold, L. H., Shore, S. K., Newkirk, T. A., Reddy, R. M., and Reddy, E. P. (1995) Multi-unit ribozyme-mediated cleavage of bcr-abl mRNA in myeloid leukemias. Blood 85, 2162-2170.
41. Ward, C. M., Acheson, N., and Seymour, L. M. (2000) Folic acid targeting of protein conjugates into ascites tumor cells from ovarian cancer patients. J. Drug Targeting 8, 119-123.
42. Lu, J. Y., Lowe, D. A., Kennedy, M. D., and Low, P. S. (1999) Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug. J Drug Targeting 7, 43-53.
43. Leamon, C. P., and Low, P. S. (1992) Cytotoxicity of Momordin-Folate Conjugates in Cultured Human Cells. J. Biol. Chem. 267, 24966-24971.
44. Leamon, C. P., Pastan, I., and Low, P. S. (1993) Cytotoxicity of Folate-Pseudomonas Exotoxin Conjugates Toward Tumor Cells. J. Biol. Chem. 268, 24847-24854.
45. Leamon, C. P., and Low, P. S. (1994) Selective Targeting of Malignant Cells with Cytotoxin-Folate Conjugates. J. Drug Targeting 2, 101-112.
46. Kranz, D. M., Patrick, T. A., Brigle, K. E., Spinella, M. J., and Roy, E. J. (1995) Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis. Proc. Natl. Acad. Sci., U.S.A. 92, 9057-9061.
47. Cho, B. K., Roy, E. J., Patrick, T. A., and Kranz, D. M. (1997) Single-chain Fv/folate conjugates mediate efficient lysis of folate-receptor-positive tumor cells. Bioconjugate Chem. 8, 338-346.
48. Kranz, D. M., Manning, T. C., Rund, L. A., Cho, B. K., Gruber, M. M., and Roy, E. J. (1998) Targeting tumor cells with bispecific antibodies and T cells. J. Controlled Release 53, 77-84.
49. Rund, L. A., Cho, B. K., Manning, T. C., Holler, P. D., Roy, E. J., and Kranz, D. M. (1999) Bispecific agents target endogenous murine T cells against human tumor xenografts. Int. J. Cancer 83, 141-149.
50. Lee, R. J., and Low, P. S. (1995) Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim. Biophys. Acta 1233, 134-144.
51. Vogel, K., Wang, S., Lee, R. J., Chmielewski, J., and Low, P. S. (1996) Peptide-mediated release of folate-targeted liposome contents from endosomal compartments. J. Am. Chem. Soc. 118, 1581-1586.
52. Rui, Y., Wang, S., Low, P. S., and Thompson, D. H. (1998) Diplasmenylcholine-folate liposomes: An efficient vehicle for intracellular drug delivery. J. Am. Chem. Soc. 120, 11213-11218.
53. Gabizon, A., Horowitz, A. T., Goren, D., Tzemach, D., Mandelbaum-Shavit, F., Qazen, M. M., and Zalipsky, S. (1999) Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjugate Chem. 10, 289-298.
54. Gottschalk, S., Cristiano, R. J., Smith, L. C., and Woo, S. L. C. (1994) Folate receptor mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expression. Gene Ther. 1, 185-191.
55. Mislick, K. A., Baldeschwieler, J. D., Kayyem, J. F., and Meade, T. J. (1995) Transfection of folate-polylysine DNA complexes: Evidence for lysosomal delivery. Bioconjugate Chem. 6, 512-515.
56. Douglas, J. T., Rogers, B. E., Rosenfeld, M. E., Michael, S. I., Feng, M., and Curiel, D. T. (1996) Targeted gene delivery by tropism-modified adenoviral vectors. Nature Biotech. 14, 1574-1578.
57. Leamon, C. P., Weigl, D., and Hendren, R. W. (1999) Folate copolymer-mediated transfection of cultured cells. Bioconjugate Chem. 10, 947-957.
58. Guo, W., and Lee, R. J. (1999) Receptor-targeted gene delivery via folate-conjugated polyethylenimine. PharmSci 1, article 19.
59. Reddy, J. A., Dean, D., Kennedy, M. D., and Low, P. S. (1999) Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy. J. Pharm. Sci. 88, 1112-1118.
60. Reddy, J. A., and Low, P. S. (2000) Enhanced folate receptor mediated gene therapy using a novel pH-senistive lipid formulation. J. Controlled Release 64, 27-37.
61. Godwin, H. A., Rosenberg, I. H., Ferenz, C. R., Jacobs, P. M., and Meienhofer, J. (1972) The synthesis of biologically active pteroyloligo-g-L-glutamates (folic acid conjugates): evaluation of [3H]pteroylheptaglutamate for metabolic studies. J. Biol. Chem. 247, 2296-2271.
62. Leamon, C. P., DePrince, R. B., and Hendren, R. W. (1999) Folate-mediated drug delivery: Effect of alternative conjugation chemistry. J. Drug Targeting 7, 157-169.
63. Riddles, P. W., Blakeley, R. L., and Zerner, B. (1979) Ellman's reagent: 5,5′-dithiobis(2-nitrobenzoic acid)- a reexamination. Anal. Biochem, 94, 75-81.
64. Leamon, C. P., and Low, P. S. (1993) Membrane Folate-binding Proteins are Responsible for Folate- protein Conjugate Endocytosis into Cultured Cells. Biochem. J. 291, 855-860.
65. Galivan, J., Ryan, T. J., Chave, K., Rhee, M., Yao, R., and Yin, D. (2000) Glutamyl hydrolase: pharmacological role and enzymatic characterization. Pharmacol. Ther. 85, 207-215.
66. Knoll, D., and Hermans, J. (1983) Polymer-protein interactions. Comparison of experiment and excluded volume theory. J. Biol. Chem. 258, 5710-5715.
67. Turk, M. J., Breur, G. J., Widmer, W. R., Paulos, C. M., Xu, L. C., Grote, L. A., and Low, P. S. (2002) Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis. Arthr. Rheum. 46, 1947-1955.